In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography
AbstractReporter gene-based strategies are widely used in experimental oncology. Bioluminescence imaging (BLI) using the firefly luciferase (Fluc) as a reporter gene and d-luciferin as a substrate is currently the most widely employed technique. The present paper compares the performances of BLI imaging with fluorescence imaging using the near infrared fluorescent protein (iRFP) to monitor brain tumor growth in mice. Fluorescence imaging includes fluorescence reflectance imaging (FRI), fluorescence diffuse optical tomography (fDOT), and fluorescence molecular Imaging (FMT®). A U87 cell line was genetically modified for constitutive expression of both the encoding Fluc and iRFP reporter genes and assayed for cell, subcutaneous tumor and brain tumor imaging. On cultured cells, BLI was more sensitive than FRI; in vivo, tumors were first detected by BLI. Fluorescence of iRFP provided convenient tools such as flux cytometry, direct detection of the fluorescent protein on histological slices, and fluorescent tomography that allowed for 3D localization and absolute quantification of the fluorescent signal in brain tumors. View Full-Text
Share & Cite This Article
Genevois, C.; Loiseau, H.; Couillaud, F. In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography. Int. J. Mol. Sci. 2016, 17, 1815.
Genevois C, Loiseau H, Couillaud F. In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography. International Journal of Molecular Sciences. 2016; 17(11):1815.Chicago/Turabian Style
Genevois, Coralie; Loiseau, Hugues; Couillaud, Franck. 2016. "In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography." Int. J. Mol. Sci. 17, no. 11: 1815.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.